-Max Healthcare to establish India`s first brain lab in New Delhi
-Max India Ltd Max telecom ventures Ltd signed a MoU
-Max India signs agreement with UK firm for health insurance biz
-Board declares Interim Dividend of 500% i.e. Rs. 10/- for every equity share of Rs. 2/- each to the shareholders.
-Ajanta Pharma Ltd has splits its face value from Rs 10/- to 5/-
- Board recommends Final Dividend 610% amounting to Rs. 12.20 per equity share of Rs. 2/- each to the shareholders.
-Ajanta Pharma has announces bonus in the ratio of 1:2
-Board recommends Final Dividendof 90%, i.e., Rs. 1.80 for every equity share of Rs. 2/- each to the shareholders
-Ajanta Pharma Announces the Launch of Montelukast Sodium Oral Granules
-Launch of Montelukast lR Tablets and Montelukast Chewable Tablets in US market
-Fortune India presents award to Ajanta Pharma
-Ajanta Pharma gets approvals for 3 ANDA''s
-Ajanta Pharma has splits its face value from Rs. 5 to Rs. 2